TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive FASEB Seeks $27.3B For NIH, Increases For Research, Training, And Infrastructure. February 1, 2002